MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment"

  • 2025 International Congress

    Analysis of Emergency Department Encounters and Hospital Admissions of People with Huntington’s Disease

    T. Orem, E. Forbes, S. Sillau (Aurora, USA)

    Objective: Define characteristics of emergency department encounters and hospital admissions of people with Huntington’s disease and identify opportunities for intervention to reduce hospitalizations. Background: Huntington’s…
  • 2025 International Congress

    Efficacy and Safety of Deutetrabenazine in Huntington’s Disease: a Systematic Review

    A. Viapiana, V. Müller, L. Lima, A. Petry, R. Juvêncio, A. Ribeiro, D. Gonçalves, M. da Rosa, G. Maia, V. Xavier (Porto Alegre, Brazil)

    Objective: To evaluate efficacy and safety of deutetrabenazine (DTB) in Huntington's Disease (HD) in order to guide evidence-based clinical decisions. Background: HD is a genetic…
  • 2025 International Congress

    Safety, Feasibility, and Effects of Time-Restricted Eating in Early-Stage Huntington’s Disease: Preliminary Analysis of a Clinical Pilot Trial

    R. Wells, L. Neilson, A. Hiller (Portland, USA)

    Objective: Evaluate whether 12 weeks of daily time-restricted eating (TRE) appears safe and feasible in persons with early-stage Huntington's disease (HD) and explore its effects…
  • 2025 International Congress

    Comparative Efficacy and Safety of VMAT2 Inhibitors for Chorea in Huntington’s Disease: A Systematic Review and Meta-Analysis

    A. Abunamoos, M. Mustafa, F. Alnajjar, Y. Aljazi, K. Moghib, N. Hamam, M. Alghaniem (Amman, Jordan)

    Objective: To assess the safety and efficacy of vesicular monoamine transporter 2 (VMAT2) inhibitors (deutetrabenazine, tetrabenazine, valbenazine) in managing chorea in Huntington’s Disease (HD). Background:…
  • 2025 International Congress

    Adult-Onset Post-Pump Chorea: A Rare Manifestation Post-Cardiac Surgery in a Puerto Rican Patient

    E. Pérez-Luciano, C. Morfi-Pagán, D. Lozada-Figueroa, L. Surillo-Dahdah (Ponce, Puerto Rico)

    Objective: To report the first case of adult-onset post-pump chorea in Puerto Rico and raise awareness of our patient’s atypical age and onset of clinical…
  • 2025 International Congress

    Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort

    JD. Ortigoza-Escobar, L. Nou-Fontanet, C. Ravelli, S. Balsells Mejia, E. Roman Schiffels, A. Innocenti, B. Villafuerte, A. Salazar, V. Quiroz, A. Sariego Jamardo, G. Bonato, A. Díaz-Gomez, A. Afenjar, C. Vilain, P. Dumke Dasilva, D. Garcia-Navas Nuñez, M. Krygier, MJ. Molnar, L. Milanowski, K. Ounap, M. Pauni, R. Borie, P. Vega, M. Villamil, S. Yilmaz, D. Zádori, M. Zawadzka, TS. Barakat, N. Sebastian, D. Natera Debenito, L. Soliani, CM. de Gusmao, G. Garone, N. Specchio, M. Carecchio, JC. Moreno, F. Magrinelli, D. Ebrahimi-Fakhari, C. Castiglioni, M. Kurian, JN. Carvalho, R. Pons, E. Flamand-Roze, D. Doummar (Barcelona, Spain)

    Objective: To analyze the clinical spectrum, genotype-phenotype correlations, and prognostic factors in NKX2-1-related disorders (NKX2-1-RD) through a multicenter study, providing insights for improved diagnosis and…
  • 2024 International Congress

    Mapping the Efficacy Landscape: A Network Meta-Analysis of Pharmacological Interventions in Huntington’s Disease

    A. Bhonsale, V. Suresh, B. Javed, M. Shamim, T. Dave, V. Ghosh, S. Sen, M. Muneer, D. Dey, M. Jayan, B. Dhakal, S. Vasipalli, R. Jena (Nagpur, India)

    Objective: To evaluate and compare the efficacy of pharmacological interventions for Huntington's Disease through a network meta-analysis, identifying the most effective treatments. Background: Huntington’s Disease…
  • 2024 International Congress

    Huntington’s Disease Pathogenesis, Molecular Factors, and Potential for Combinatorial Therapies: A Focus on BDNF and NMDA Receptor Therapies

    M. Mistry, J. Pace, E. Guivatchian, J. Hinman (Fort Worth, USA)

    Objective: This paper outlines current therapeutic options for HD, and ultimately suggests taking a combinatorial therapeutic approach to slow HD progression by simultaneously treating multiple…
  • 2024 International Congress

    Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration

    RN. Surbakti, RK. Praja (Palangka Raya, Indonesia)

    Objective: This study aimed to investigate the shifting trends (2019-2024) in research on Huntington's disease (HD)based on bibliometric lens. Background: Huntington's disease is a movement…
  • 2024 International Congress

    Exploring the Impact of Mechanoacoustic Vibration Therapy on Mobility, Bone Density, and Postural Stability in Perimenopause Women with Huntington’s disease

    S. Devi, R. Chauhan (Narsan, India)

    Objective: This study aimed to investigate the effects of mechanoacoustic vibration therapy on mobility, bone mineral density (BMD), and postural instability in perimenopause  women with…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley